{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:14:05Z","timestamp":1772640845597,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002770","name":"Cabinet Office, Government of Japan","doi-asserted-by":"publisher","award":["BRIDGE"],"award-info":[{"award-number":["BRIDGE"]}],"id":[{"id":"10.13039\/501100002770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>PREDICT is a prognostic tool developed in the United Kingdom to estimate postoperative overall survival (OS) and the additional benefits of adjuvant therapies in patients with breast cancer. It has been validated in various international cohorts and continuously updated with the inclusion of new variables and model retraining. However, their efficacy in the Japanese population remains unclear. We aimed to evaluate the generalizability of PREDICT versions 2.2 (v2.2) and 3.0 (v3.0) using data from the National Cancer Center Hospital in Japan, a high-volume cancer center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed a retrospective cohort (2006\u20132016) including 2,980 cases of postoperative breast cancer. We calculated survival predictions using both v2.2 and v3.0, and compared them with the Kaplan\u2013Meier-estimated survival probabilities using a calibration plot. Additionally, we performed a time-dependent receiver operating characteristic (ROC) curve analysis for v2.2 and v3.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both models tended to underestimate survival in our cohort, whereas v3.0 showed improved calibration compared to v2.2, for 5- and 10-year OS. Both v2.2 and v3.0 maintained good discriminative performance throughout 10 years, with values under the ROC curve generally above 0.80.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite these differences, both versions demonstrated satisfactory performance, suggesting that they can be generalized for Japanese patients with postoperative breast cancer. Notably, v3.0, given its improved calibration, might be more suitable for supporting shared decision making. The model\u2019s performance in predicting 5-year OS supports its generalizability, whereas 10-year projections warrant caution due to limited follow-up. Overall, this study demonstrates that PREDICT is a valuable prognostic tool for Japanese patients with breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12282-026-01823-w","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T06:14:19Z","timestamp":1768803259000},"page":"415-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of the postoperative prognostication tool PREDICT version 2.2 and 3.0 using data from the National cancer center hospital in Japan"],"prefix":"10.1007","volume":"33","author":[{"given":"Hiromi","family":"Hashiguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2061-2111","authenticated-orcid":false,"given":"Nobuji","family":"Kouno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Shiino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Obama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D. P.","family":"Pharoah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2632-1334","authenticated-orcid":false,"given":"Ryuji","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"1823_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1823_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15\u201323.","journal-title":"Breast"},{"key":"1823_CR3","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1158\/1055-9965.EPI-23-0754","volume":"32","author":"PT Nguyen","year":"2023","unstructured":"Nguyen PT, Hori M, Matsuda T, Katanoda K. Cancer prevalence projections in Japan and decomposition analysis of changes in cancer Burden, 2020\u20132050: A statistical modeling study. Cancer Epidemiol Biomarkers Prev. 2023;32:1756\u201370.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1823_CR4","first-page":"721","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang J, Wu SG. Breast cancer: an overview of current therapeutic Strategies, Challenge, and perspectives. Breast Cancer (Dove Med Press). 2023;15:721\u201330.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"1823_CR5","doi-asserted-by":"publisher","first-page":"ed119","DOI":"10.3332\/ecancer.2021.ed119","volume":"15","author":"YF Gu","year":"2021","unstructured":"Gu YF, Lin FP, Epstein RJ. How aging of the global population is changing oncology. Ecancermedicalscience. 2021;15:ed119.","journal-title":"Ecancermedicalscience"},{"key":"1823_CR6","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/bcr2464","volume":"12","author":"GC Wishart","year":"2010","unstructured":"Wishart GC, Azzato EM, Greenberg DC, Rashbass J, Kearins O, Lawrence G, et al. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res. 2010;12:R1.","journal-title":"Breast Cancer Res"},{"key":"1823_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/sj.bjc.6605283","volume":"101","author":"H Campbell","year":"2009","unstructured":"Campbell H, Taylor M, Harris A, Gray A. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the united Kingdom. Br J Cancer. 2009;101:1074\u201384.","journal-title":"Br J Cancer"},{"key":"1823_CR8","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1002\/cncr.24565","volume":"115","author":"L Chen","year":"2009","unstructured":"Chen L, Nolan M, Silverstein M. The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death. Cancer. 2009;115:5071\u201383.","journal-title":"Cancer"},{"key":"1823_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/bjc.2015.466","volume":"114","author":"NA de Glas","year":"2016","unstructured":"de Glas NA, Bastiaannet E, Engels CC, de Craen AJM, Putter H, van de Velde CJH, et al. Validity of the online PREDICT tool in older patients with breast cancer: a population-based study. Br J Cancer. 2016;114:395\u2013400.","journal-title":"Br J Cancer"},{"key":"1823_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/bjc.2015.57","volume":"112","author":"T Maishman","year":"2015","unstructured":"Maishman T, Copson E, Stanton L, Gerty S, Dicks E, Durcan L, et al. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged \u2a7d40 years at breast cancer diagnosis. Br J Cancer. 2015;112:983\u201391.","journal-title":"Br J Cancer"},{"key":"1823_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.6004\/jnccn.2023.7048","volume":"21","author":"N Stabellini","year":"2023","unstructured":"Stabellini N, Cao L, Towe CW, Miller ME, Sousa-Santos AH, Amin AL, et al. Validation of the PREDICT prognostication tool in US patients with breast cancer. J Natl Compr Canc Netw. 2023;21:1011\u2013e96.","journal-title":"J Natl Compr Canc Netw"},{"key":"1823_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejso.2011.02.001","volume":"37","author":"GC Wishart","year":"2011","unstructured":"Wishart GC, Bajdik CD, Azzato EM, Dicks E, Greenberg DC, Rashbass J, et al. A population-based validation of the prognostic model PREDICT for early breast cancer. Eur J Surg Oncol (EJSO). 2011;37:411\u20137.","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"1823_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2017.03.015","volume":"78","author":"EG Engelhardt","year":"2017","unstructured":"Engelhardt EG, van den Broek AJ, Linn SC, Wishart GC, Rutgers EJT, van de Velde AO, et al. Accuracy of the online prognostication tools PREDICT and Adjuvant! For early-stage breast cancer patients younger than 50 years. Eur J Cancer. 2017;78:37\u201344.","journal-title":"Eur J Cancer"},{"key":"1823_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejca.2017.09.031","volume":"86","author":"MC van Maaren","year":"2017","unstructured":"van Maaren MC, van Steenbeek CD, Pharoah PDP, Witteveen A, Sonke GS, Strobbe LJA, et al. Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population. Eur J Cancer. 2017;86:364\u201372.","journal-title":"Eur J Cancer"},{"key":"1823_CR15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/jep.13084","volume":"25","author":"U Aguirre","year":"2019","unstructured":"Aguirre U, Garc\u00eda-Guti\u00e9rrez S, Romero A. External validation of the PREDICT tool in Spanish women with breast cancer participating in population\u2010based screening programmes. J Eval Clin Pract. 2019;25:873\u201380.","journal-title":"J Eval Clin Pract"},{"key":"1823_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13058-017-0852-3","volume":"19","author":"FJ Candido dos Reis","year":"2017","unstructured":"Candido dos Reis FJ, Wishart GC, Dicks EM, Greenberg D, Rashbass J, Schmidt MK, et al. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation. Breast Cancer Res. 2017;19:58.","journal-title":"Breast Cancer Res"},{"key":"1823_CR17","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3892\/ol.2014.2589","volume":"8","author":"SK Down","year":"2014","unstructured":"Down SK, Lucas O, Benson JR, Wishart GC. Effect of PREDICT on chemotherapy\/trastuzumab recommendations in HER2\u2013positive patients with early\u2013stage breast cancer. Oncol Lett. 2014;8:2757\u201361.","journal-title":"Oncol Lett"},{"key":"1823_CR18","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1186\/1471-2407-14-908","volume":"14","author":"GC Wishart","year":"2014","unstructured":"Wishart GC, Rakha E, Green A, Ellis I, Ali HR, Provenzano E, et al. Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer. BMC Cancer. 2014;14:908.","journal-title":"BMC Cancer"},{"key":"1823_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejca.2022.06.011","volume":"173","author":"I Grootes","year":"2022","unstructured":"Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, et al. Incorporating progesterone receptor expression into the PREDICT breast prognostic model. Eur J Cancer. 2022;173:178\u201393.","journal-title":"Eur J Cancer"},{"key":"1823_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41523-024-00612-y","volume":"10","author":"I Grootes","year":"2024","unstructured":"Grootes I, Wishart GC, Pharoah PDP. An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy. Npj Breast Cancer. 2024;10:6.","journal-title":"Npj Breast Cancer"},{"key":"1823_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/jncimonographs\/lgae028","volume":"2024","author":"P Murphy","year":"2024","unstructured":"Murphy P, Sellers M, Bonds S, Scott S. The SEER program\u2019s longstanding commitment to making cancer resources available. J Natl Cancer Inst Monogr. 2024;2024:118\u201322.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1823_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.6004\/jnccn.2025.7014","volume":"23","author":"Y-W Hsiao","year":"2025","unstructured":"Hsiao Y-W, Wishart GC, Pharoah PDP, Peng P-C. Assessing the performance of the PREDICT breast version 3.0 prognostic tool in patients with breast cancer in the united States. J Natl Compr Canc Netw. 2025;23:227\u201333.","journal-title":"J Natl Compr Canc Netw"},{"key":"1823_CR23","doi-asserted-by":"crossref","unstructured":"Nair NS, Kothari B, Gupta S, Kanann S, Vanmali V, Hawaldar R et al. Validation of PREDICT version 2.2 in a retrospective cohort of Indian women with operable breast cancer. JCO Global Oncol. 2023: e2300114.","DOI":"10.1200\/GO.23.00114"},{"key":"1823_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.18678\/dtfd.1419974","volume":"26","author":"Z Zahar\u0131","year":"2024","unstructured":"Zahar\u0131 Z, Chee Keong K, Wan Zain WZ, Yahya MM, Mohamad H. Use of NHS PREDICT tool and prognostic factors for survival in patients with breast cancer. Duzce Med J. 2024;26:105\u201311.","journal-title":"Duzce Med J"},{"key":"1823_CR25","doi-asserted-by":"publisher","first-page":"e976","DOI":"10.1093\/oncolo\/oyae164","volume":"29","author":"E Chen","year":"2024","unstructured":"Chen E, Chen C, Chen Y, You J, Jin C, Huang Z, et al. Insights into the performance of PREDICT tool in a large Mainland Chinese breast cancer cohort: a comparative analysis of versions 3.0 and 2.2. Oncologist. 2024;29:e976\u201383.","journal-title":"Oncologist"},{"key":"1823_CR26","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/cam4.3713","volume":"10","author":"K Zaguirre","year":"2021","unstructured":"Zaguirre K, Kai M, Kubo M, Yamada M, Kurata K, Kawaji H, et al. Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients. Cancer Med. 2021;10:1605\u201313.","journal-title":"Cancer Med"},{"key":"1823_CR27","first-page":"91","volume":"7","author":"WN Dudley","year":"2016","unstructured":"Dudley WN, Wickham R, Coombs N. An introduction to survival statistics: Kaplan-Meier analysis. J Adv Pract Oncol. 2016;7:91\u2013100.","journal-title":"J Adv Pract Oncol"},{"key":"1823_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","volume":"17","author":"AN Kamarudin","year":"2017","unstructured":"Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17:53.","journal-title":"BMC Med Res Methodol"},{"key":"1823_CR29","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, et al. Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA. 2017;318:1377\u201384.","journal-title":"JAMA"},{"key":"1823_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1472-6947-7-35","volume":"7","author":"E Barbini","year":"2007","unstructured":"Barbini E, Cevenini G, Scolletta S, Biagioli B, Giomarelli P, Barbini P. A comparative analysis of predictive models of morbidity in intensive care unit after cardiac surgery \u2013 Part I: model planning. BMC Med Inf Decis Mak. 2007;7:35.","journal-title":"BMC Med Inf Decis Mak"},{"key":"1823_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12874-023-01974-w","volume":"23","author":"CCHM Maas","year":"2023","unstructured":"Maas CCHM, Kent DM, Hughes MC, Dekker R, Lingsma HF, van Klaveren D. Performance metrics for models designed to predict treatment effect. BMC Med Res Methodol. 2023;23:165.","journal-title":"BMC Med Res Methodol"},{"key":"1823_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW, Bossuyt P, et al. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17:230.","journal-title":"BMC Med"},{"key":"1823_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3348\/kjr.2025.0338","volume":"26","author":"N Chotai","year":"2025","unstructured":"Chotai N, Renganathan R, Uematsu T, Wang J, Zhu Q, Rahmat K, et al. Breast cancer screening in Asian countries: Epidemiology, screening Practices, Outcomes, Challenges, and future directions. Korean J Radiol. 2025;26:743\u201358.","journal-title":"Korean J Radiol"},{"key":"1823_CR34","doi-asserted-by":"publisher","first-page":"i13","DOI":"10.1093\/jjco\/hyq122","volume":"40","author":"M Toi","year":"2010","unstructured":"Toi M, Ohashi Y, Seow A, Moriya T, Tse G, Sasano H, et al. The breast cancer working group presentation was divided into three sections: the Epidemiology, pathology and treatment of breast cancer. Jpn J Clin Oncol. 2010;40:i13\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"1823_CR35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/jamaoncol.2019.0620","volume":"5","author":"Y-S Yap","year":"2019","unstructured":"Yap Y-S, Lu Y-S, Tamura K, Lee JE, Ko EY, Park YH, et al. Insights into breast cancer in the East vs the west: A review. JAMA Oncol. 2019;5:1489\u201396.","journal-title":"JAMA Oncol"},{"key":"1823_CR36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10549-020-05869-y","volume":"184","author":"R Ogiya","year":"2020","unstructured":"Ogiya R, Niikura N, Kumamaru H, Takeuchi Y, Okamura T, Kinoshita T, et al. Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study. Breast Cancer Res Treat. 2020;184:585\u201396.","journal-title":"Breast Cancer Res Treat"},{"key":"1823_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12911-023-02377-z","volume":"23","author":"D Zuo","year":"2023","unstructured":"Zuo D, Yang L, Jin Y, Qi H, Liu Y, Ren L. Machine learning-based models for the prediction of breast cancer recurrence risk. BMC Med Inf Decis Mak. 2023;23:276.","journal-title":"BMC Med Inf Decis Mak"},{"key":"1823_CR38","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.3390\/ijerph20042985","volume":"20","author":"MN Nik Ab Kadir","year":"2023","unstructured":"Nik Ab Kadir MN, Mohd Hairon S, Yaacob NM, Yusof SN, Musa KI, Yahya MM, et al. myBeST\u2014A Web-Based survival prognostic tool for women with breast cancer in malaysia: development process and preliminary validation study. Int J Environ Res Public Health. 2023;20:2985.","journal-title":"Int J Environ Res Public Health"},{"key":"1823_CR39","doi-asserted-by":"publisher","first-page":"30248","DOI":"10.1038\/s41598-025-16331-8","volume":"15","author":"Y Xu","year":"2025","unstructured":"Xu Y, Li B, Zou B, Fan B, Wang S, Yu J, et al. Deep learning for survival prediction in triple-negative breast cancer: development and validation in real-world cohorts. Sci Rep. 2025;15:30248.","journal-title":"Sci Rep"},{"key":"1823_CR40","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1002\/sim.8682","volume":"39","author":"J Hoogland","year":"2020","unstructured":"Hoogland J, van Barreveld M, Debray TPA, Reitsma JB, Verstraelen TE, Dijkgraaf MGW, et al. Handling missing predictor values when validating and applying a prediction model to new patients. Stat Med. 2020;39:3591\u2013607.","journal-title":"Stat Med"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01823-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:57:28Z","timestamp":1772621848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01823-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01823-w","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}